Hottest Stocks: Cheniere Energy Partners LP. (NYSEMKT:CQP), Vical Incorporated (NASDAQ:VICL), Dicerna Pharmaceuticals (NASDAQ:DRNA), Radius Health (NASDAQ:RDUS)


CPI Aerostructures Inc. (NYSEMKT:CVU) shares moved down -12.50% in last trading session and ended the day at $8.05. CVU Gross Margin is 19.50% and its has a return on assets of 5.50%. CPI Aerostructures Inc. (NYSEMKT:CVU) quarterly performance is -16.92%.

CPI Aerostructures, Inc. (NYSE MKT: CVU) announced it plans to temporarily delay its 2015 fourth quarter and fiscal year earnings release and conference call and webcast, previously scheduled for Thursday, March 3, 2016. The company needs additional time to complete the review of its financial results for the fourth quarter and full year 2015.

Cheniere Energy Partners LP. (NYSEMKT:CQP) ended the last trading day at $27.27. Company weekly volatility is calculated as 5.94% and price to cash ratio as 63.01. Cheniere Energy Partners LP. (NYSEMKT:CQP) showed a weekly performance of 10.58%.

On 26 February, Cheniere Energy Partners, L.P. (NYSE MKT: CQP) announced that it has closed on the previously announced approximately $2.8 billion of senior secured credit facilities. The four-year credit facilities consist of an approximately $450 million Cheniere Creole Trail Pipeline, L.P. (“CCTP”) tranche term loan, an approximately $2.1 billion Sabine Pass LNG, L.P. (“SPLNG”) tranche term loan, and an approximately $240 million revolving credit facility. Pricing for these facilities is London Interbank Offered Rate (LIBOR) plus 225 basis points or the base rate plus 125 basis points, in each case with a 50 basis point step-up beginning on the third anniversary of the closing.

On 03 March, Vical Incorporated (NASDAQ:VICL) shares moved down -0.14% and was closed at $0.37. VICL EPS growth in last 5 year was 20.80%. Vical Incorporated (NASDAQ:VICL) year to date (YTD) performance is -9.88%.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares moved up 4.29% in last trading session and ended the day at $5.59. DRNA has a return on assets of -56.50%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) quarterly performance is -61.37%.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the 23rd Annual Future leaders in the Biotech Industry Conference. Dicerna’s presentation will take place on Friday, March 11th, 2016, at 11:30 a.m. ET at the Millennium Broadway Hotel & Conference Center in New York City.

Radius Health, Inc. (NASDAQ:RDUS) caters to the Healthcare space. Its weekly performance is -0.58%. On the last day of trading company shares ended up at $30.74. Radius Health, Inc. (NASDAQ:RDUS) distance from 50-day simple moving average (SMA50) is 1.07%.

Radius Health, Inc. (NASDAQ:RDUS) reported a net loss of $33.2 million, or $0.77 per share, as compared to a net loss of $18.0 million, or $0.55 per share for the three months ended December 31, 2014. The increase in net loss for the three months ended December 31, 2015 as compared to the three months ended December 31, 2014 was primarily due to an increase in research and development and general and administrative expenses, partially offset by a decrease in interest expense.


Leave a Reply

Your email address will not be published. Required fields are marked *